KOPP INVESTMENT ADVISORS LLC - Q3 2015 holdings

$186 Million is the total value of KOPP INVESTMENT ADVISORS LLC's 78 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 40.0% .

 Value Shares↓ Weighting
OCLR BuyOclaro, Inc.$25,082,000
+3.1%
10,905,229
+1.3%
13.49%
+24.5%
EMKR BuyEmcore Corp.$21,996,000
+14.4%
3,234,723
+1.3%
11.83%
+38.1%
IG BuyIGI Laboratories, Inc.$12,631,000
+7.6%
1,931,320
+3.7%
6.79%
+30.0%
XENT BuyIntersect ENT Inc.$10,268,000
-14.2%
438,809
+5.0%
5.52%
+3.7%
IL BuyIntraLinks Holdings Inc.$5,186,000
-27.8%
625,560
+3.8%
2.79%
-12.8%
AKRXQ BuyAkorn, Inc.$2,704,000
-33.5%
94,850
+1.8%
1.45%
-19.7%
LGND BuyLigand Pharmaceuticals Inc$2,699,000
-3.9%
31,508
+13.2%
1.45%
+16.1%
CEMP BuyCempra, Inc$2,648,000
-14.7%
95,121
+5.3%
1.42%
+3.0%
NXTM BuyNxStage Medical, Inc$2,346,000
+40.6%
148,757
+27.3%
1.26%
+69.9%
SCON BuySuperconductor Technologies, Inc.$1,933,000
-28.3%
3,117,779
+21.5%
1.04%
-13.3%
KTWO NewK2M Grp Hldgs$1,904,000102,351
+100.0%
1.02%
QRVO BuyQorvo$1,689,000
-13.1%
37,491
+54.8%
0.91%
+4.8%
CVLT BuyCommVault Systems Inc.$1,088,000
+86.3%
32,036
+132.8%
0.58%
+125.0%
CMI NewCummins Inc.$865,0007,970
+100.0%
0.46%
JNJ BuyJohnson & Johnson$834,000
-4.0%
8,938
+0.3%
0.45%
+16.0%
PG BuyThe Procter & Gamble Company$802,000
-7.7%
11,147
+0.3%
0.43%
+11.4%
VG NewVonage Holdings Corp.$788,000134,055
+100.0%
0.42%
HAL NewHalliburton Company$721,00020,385
+100.0%
0.39%
QCOM BuyQUALCOMM Inc.$677,000
-13.9%
12,605
+0.4%
0.36%
+4.0%
XOM BuyExxon Mobil Corporation$632,000
-10.4%
8,505
+0.4%
0.34%
+8.3%
EGRX BuyEagle Pharmaceuticals, Inc.$397,000
-2.9%
5,358
+6.1%
0.21%
+17.6%
SIEN BuySientra, Inc.$243,000
-9.3%
23,910
+125.2%
0.13%
+10.1%
AVGR NewAvinger, Inc.$222,00015,060
+100.0%
0.12%
SBUX NewStarbucks Corp.$210,0003,695
+100.0%
0.11%
INTC NewIntel Corp.$200,0006,644
+100.0%
0.11%
VCYT BuyVeracyte Inc.$190,000
-56.3%
40,410
+3.4%
0.10%
-47.4%
HWAY BuyHealthways Inc.$173,000
-3.9%
15,590
+3.7%
0.09%
+16.2%
LXRX NewLexicon Pharmaceuticals Inc.$129,00012,020
+100.0%
0.07%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NeoGenomics Inc.26Q3 20198.2%
RTI Surgical Inc.26Q3 20196.0%
Omnicell Inc.26Q3 20194.7%
AtriCure Inc.26Q3 20194.6%
Ligand Pharmaceuticals Inc.26Q3 20194.5%
SPDR Trust Ser 126Q3 20192.3%
Marriott Intl. Inc.26Q3 20191.5%
Southwest Airls Co.26Q3 20191.3%
3M Company26Q3 20191.2%
Aflac Incorporated26Q3 20191.1%

View KOPP INVESTMENT ADVISORS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
KOPP INVESTMENT ADVISORS LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
SUPERCONDUCTOR TECHNOLOGIES INCAugust 19, 2016528,96316.6%
EMCORE CORPApril 01, 20161,248,9704.8%
VITESSE SEMICONDUCTOR CORPMay 05, 2015? ?
TRANSGENOMIC INCMay 23, 201483,5021.1%
RTI SURGICAL, INC.January 03, 20141,984,6183.5%
SYNERGETICS USA INCJanuary 03, 2014877,2533.5%
MINDSPEED TECHNOLOGIES, INCDecember 13, 20132,068,4164.8%
TRANSGENOMIC INCNovember 01, 201313,744,08615.6%
OCLARO, INC.September 20, 20138,592,5179.3%
SUPERCONDUCTOR TECHNOLOGIES INCDecember 21, 20128,776,33517.4%

View KOPP INVESTMENT ADVISORS LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR/A2018-08-15
13F-HR2018-08-14
13F-HR2018-05-14
13F-HR2018-02-14
13F-HR2017-11-14

View KOPP INVESTMENT ADVISORS LLC's complete filings history.

Compare quarters

Export KOPP INVESTMENT ADVISORS LLC's holdings